Z-1327-2020 Class II Terminated

Recalled by The Binding Site Group, Ltd. — Birmingham

FDA device recall Z-1327-2020 was initiated by The Binding Site Group, Ltd. on Jul 29, 2019 and is designated Class II. Reason for recall: There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in… The recall status is terminated (terminated Jan 13, 2022). Affected quantity: 3294 kits.

Recall details

Product Type
Devices
Report Date
Feb 26, 2020
Initiation Date
Jul 29, 2019
Termination Date
Jan 13, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3294 kits

Product description

OPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565

Reason for recall

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Distribution pattern

CA, PA, FL, AR, SD, MA, WV, AL, GA, IL, MN, MD, AZ, NC, TN, WA, MI, NY, KY, SC, IN, OR, NE, OH, TX, VT, WA, UT, IA,

Code information

Lot # 422251

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1327-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1327-2020. Report a data issue: hello@regdatalab.com.